Urologix, Inc. ULGX
Set alert
At close · Oct 29
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0001
- Prev close
- 0.0001
- Mkt cap
- 2.18K
- Vol
- 125
- Avg vol
- 1.31K
- EPS
- -0.02
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0001
- High
- 0.0001
- Forward P/E
- 0.00
- Beta
- 5.55
- Short ratio
- 1.02
- Inst. own
- 0.20%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.001399
- 200-d avg
- 0.00129
- 1y target
- 1.50
Key statistics
- Market cap
- 23.41K
- Enterprise value
- 0
- Trailing P/E
- -0.01
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- -0.217
- Beta
- 5.55
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -38.90%
- Revenue (TTM)
- 12.00M
- Revenue growth
- -16.70%
- Free cash flow
- 725.88K
- Total cash
- 492.00K
- Total debt
- 5.33M
- Return on equity
- 0.00%
- Shares outstanding
- 21.28M
- Short % of float
- 0.30%
- 50-day average
- 0.001399
- 200-day average
- 0.00129
Analyst view
Consensus: strong buy
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 12, 2015 | Mar 1, 2015 | 0.00 | -0.02 | — | — |
| Feb 5, 2015 | Dec 1, 2014 | 0.00 | -0.02 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 16, 2012 | Dougherty & Company | init | — | Buy |
| Oct 28, 2007 | Feltl & Co. | down | Buy | Hold |
| Jul 17, 2007 | Feltl & Co. | init | — | Buy |
| Apr 12, 2007 | CE Unterberg Towbin | down | Market Perform | Underperform |
| Jan 25, 2007 | CE Unterberg Towbin | up | Underperform | Market Perform |
| Aug 16, 2006 | CE Unterberg Towbin | down | Market Perform | Underperform |
About Urologix, Inc.
Urologix, Inc. develops, manufactures, and markets non-surgical, office-based therapies for the treatment of the symptoms and obstruction resulting from benign prostatic hyperplasia (BPH). The company offers Cooled ThermoTherapy product line, which includes the CoolWave and Targis Control Units, and the CTC Advance catheter for the production of targeted microwave energy combined with a unique cooling mechanism to protect healthy urethral tissue and enhance patient comfort. It also distributes Prostiva RF Therapy Systems, which delivers radio frequency energy directly into the prostate and destroys prostate tissue that reduces constriction of the urethra and relieves BPH voiding symptoms. The company distributes its products to urologist offices, ambulatory surgery centers, and hospitals through its direct sales force and local distributors in the United States and internationally. Urologix, Inc was founded in 1991 and is based in Minneapolis, Minnesota.
- Sector
- Healthcare
- Industry
- Medical Appliances & Equipment
- Country
- United States
- Website
- urologix.com
News
Your note
Sign in to keep a note on ULGX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| MADSON SCOTT M. | Officer | Ownership Statement | Mar 31, 2015 | 0 |